Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Increased K-ras mutation and expression of S100A4 and MUC2 protein in the malignant intraductal papillary mucinous tumor of the pancreas.

Journal of hepato-biliary-pancreatic surgery - 1 Jan 2009

Jang Jin-Young, Park Yoon-Chan, Song Yoon Sup, Lee Seung Eun, Hwang Dae Wook, Lim Chang-Sup, Lee Hee Eun, Kim Woo Ho, Kim Sun-Whe

Abstract excerpt

PURPOSE: The purpose of this study was to document the biological changes during the progression of intraductal papillary mucinous neoplasm of the pancreas (IPMN) and to identify biological markers capable of differentiating benign and malignant IPMN. METHODS: Forty-one patients with IPMN who underwent resection between 1994 and 2003 were enrolled in this study. The paraffin-embedded tumors from 27 with benign...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Adenocarcinoma, Mucinous
Share to Biopsy, Needle

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Carcinoma, Pancreatic Ductal

Share to Mucin-2

Share to Pancreatic Neoplasms

Share to Probability

Share to S100 Proteins

Share to Statistics, Nonparametric

Source

Identifiers

PMID: 19412570
DOI: 10.1007/s00534-009-0105-7

Genes

MUC2

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Increased K-ras mutation and expression of S100A4 and MUC2 protein in the malignant intraductal papillary mucinous tumor of the pancreas.PMID 19412570Read ↗

Histologic, immunohistochemical, and molecular classification of 52 IPMNs of the pancreas.Semantic proximity Read ↗

Intraductal papillary mucinous neoplasms of the pancreas: Clinical association with KRAS.Semantic proximity Read ↗

Characterization of K-ras gene mutations in association with mucinous hypersecretion in intraductal papillary-mucinous neoplasms.Semantic proximity Read ↗

Molecular pathology of intraductal papillary mucinous neoplasms of the pancreas.Semantic proximity Read ↗

Prevalence of Activating K-ras Mutations in the Evolutionary Stages of Neoplasia in Intraductal Papillary Mucinous Tumors of the PancreasSemantic proximity Read ↗

Molecular biomarkers for progression of intraductal papillary mucinous neoplasm of the pancreas.Semantic proximity Read ↗

Molecular characteristics and biological behaviours of the oncocytic and pancreatobiliary subtypes of intraductal papillary mucinous neoplasmsSemantic proximity Read ↗

GNAS and KRAS Mutations Define Separate Progression Pathways in Intraductal Papillary Mucinous Neoplasm-Associated Carcinoma.Semantic proximity Read ↗

Loss of PTEN expression is associated with poor prognosis in patients with intraductal papillary mucinous neoplasms of the pancreas.Semantic proximity Read ↗

Targeted next-generation sequencing of cancer genes dissects the molecular profiles of intraductal papillary neoplasms of the pancreas.Semantic proximity Read ↗

High-throughput mutation profiling in intraductal papillary mucinous neoplasm (IPMN).Semantic proximity Read ↗

Relevance of gene mutations and methylation to the growth of pancreatic intraductal papillary mucinous neoplasms based on pyrosequencing.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.